Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Organizational prerequisites for multimodality therapy concepts].

M Siess¹, R Bumm, M Molls

¹Klinikum rechts der Isar, Technische Universität München, Ismaningerstrasse 22, 81675 München.

Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress

|February 5, 2002

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correction to: Prospective multicentre randomized double‑blind placebo‑controlled parallel group study on the efficacy and tolerability of StroVac® in patients with recurrent symptomatic uncomplicated bacterial urinary tract infections.

International urology and nephrology·2023

Same author

Prospective multicentre randomized double-blind placebo-controlled parallel group study on the efficacy and tolerability of StroVac® in patients with recurrent symptomatic uncomplicated bacterial urinary tract infections.

International urology and nephrology·2022

Same author

Re-activation of mitochondrial apoptosis inhibits T-cell lymphoma survival and treatment resistance.

Leukemia·2016

Same author

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey.

Leukemia·2015

Same author

Blockade of BCL-2 proteins efficiently induces apoptosis in progenitor cells of high-risk myelodysplastic syndromes patients.

Leukemia·2015

Same author

Cks1 is a critical regulator of hematopoietic stem cell quiescence and cycling, operating upstream of Cdk inhibitors.

Oncogene·2014

Multimodal therapies require new clinic structures for better collaboration between specialized disciplines. Establishing disease-oriented teams and daily tumor boards improves treatment coordination and quality management.

Area of Science:

Oncology
Healthcare Management
Clinical Organization

Context:

The rise of multimodal cancer therapies necessitates adaptive clinical organizational structures.
High specialization in medical disciplines challenges integrated patient care.
Evaluating treatment stages and coordinating complex therapeutic pathways require enhanced collaboration.

Purpose:

To outline the organizational requirements for implementing multimodal therapies.
To propose solutions for improving interdisciplinary cooperation in clinical settings.
To address challenges in quality management and treatment coordination for complex therapies.

Summary:

Multimodal therapies demand new organizational frameworks within clinics.
Establishing disease-oriented structures and institutionalizing interdisciplinary cooperation are key.

Related Experiment Videos

Daily tumor boards and fixed disease management teams facilitate the necessary collaboration.

Impact:

Improved coordination of multimodal treatment plans.
Enhanced quality management in complex therapeutic pathways.
Creation of organizational prerequisites for effective multimodal therapy implementation.